Feher Miklos, Gao Yinghong, Baber J Christian, Shirley William A, Saunders John
Neurocrine Biosciences, 12790 El Camino Real, San Diego, CA 92130, USA.
Bioorg Med Chem. 2008 Jan 1;16(1):422-7. doi: 10.1016/j.bmc.2007.09.026. Epub 2007 Sep 18.
This paper describes the application of de novo design utilizing exclusively ligand information. In the current approach, ligand design criteria, including pharmacophores, similarity and desired properties are applied as part of a fitness function driving the design process, instead of using them as filters after the process. This allows relevant parts of chemical space to be explored more efficiently. Two case studies of successful ligand design are also presented, one aimed at scaffold hopping, the other for exploring substitution patterns around a novel scaffold.
本文描述了仅利用配体信息进行从头设计的应用。在当前方法中,配体设计标准,包括药效团、相似性和所需性质,被用作驱动设计过程的适应度函数的一部分,而不是在设计过程之后将它们用作过滤器。这使得能够更有效地探索化学空间的相关部分。还介绍了两个成功的配体设计案例研究,一个旨在骨架跃迁,另一个用于探索新型骨架周围的取代模式。